[EFFICACY AND SAFETY OF INITIAL DESMOPRESSIN DOSE OF 50 μg IN ELDERLY MALE PATIENTS WITH NOCTURNAL POLYURIA].

Author: ChikuiKatsuaki, IgawaTsukasa, KomiyaKeisuke, KuroseHirofumi, MatsuoMitsunori, NakiriMakoto, NishiharaKiyoaki, OgasawaraNaoyuki, SuekaneShigetaka, UedaKosuke

Paper Details 
Original Abstract of the Article :
(Introduction) Low-dose desmopressin is now available for the treatment of nocturia associated with nocturnal polyuria in men, and its usefulness in a dose-dependent manner has been reported. Since side effects such as hyponatremia have reported frequently, the initial dose has been set at 25 μg in ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.5980/jpnjurol.113.115

データ提供:米国国立医学図書館(NLM)

Desmopressin for Nocturnal Polyuria in Elderly Men: Efficacy and Safety of Higher Doses

Nocturnal polyuria, a condition characterized by excessive urination at night, can significantly disrupt sleep and affect quality of life, particularly in elderly individuals. This research investigates the efficacy and safety of desmopressin, a medication used to treat nocturnal polyuria, in elderly male patients. The authors focus on the potential benefits of initiating desmopressin treatment at a higher dose of 50 μg, challenging the conventional practice of starting with a lower dose. Their findings suggest that a higher initial dose of desmopressin can effectively reduce nocturnal urination, improve sleep quality, and be safely administered in elderly patients with appropriate monitoring.

Optimizing Treatment: Tailoring Desmopressin Doses for Elderly Patients

This research offers valuable insights into the optimal dosing strategy for desmopressin in elderly patients with nocturnal polyuria. The study highlights the potential benefits of starting with a higher initial dose, leading to faster symptom relief and potentially improved adherence to treatment. The authors emphasize the importance of close monitoring and adjusting doses based on individual patient responses, ensuring both efficacy and safety.

A More Restful Night: Improving Sleep Quality for Elderly Individuals

This study offers a glimmer of hope for elderly individuals struggling with nocturnal polyuria. By demonstrating the efficacy and safety of a higher initial dose of desmopressin, the research suggests a potential for more effective treatment and improved sleep quality. This research emphasizes the importance of individualized care and tailoring treatment strategies to meet the unique needs of elderly patients, promoting better health and a more comfortable night's rest.

Dr. Camel's Conclusion

The desert of aging can be a challenging journey, often marked by sleep disturbances and the need for individualized care. This study suggests a potential for optimizing desmopressin treatment for elderly men with nocturnal polyuria, offering a path towards a more restful night and a better quality of life. By carefully monitoring and adjusting doses, we can empower healthcare providers to offer personalized care and ensure a more comfortable journey through the desert of aging.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-10-30
Further Info :

Pubmed ID

37866930

DOI: Digital Object Identifier

10.5980/jpnjurol.113.115

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.